A Study to Investigate the Pharmacokinetics and Safety of KM04 Compared to United States (US)-Gonal-f Revised Formulation Female (RFF) Redi-ject and European Union (EU)-Gonal-f in Healthy Adult Female Volunteers

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2026
A Single Center, Single‐Dose, Double‐Blind, Randomized, Three‐Treatment, Three‐Period,Six‐Sequence, Crossover Study to Demonstrate Pharmacokinetic Similarity Between KM04,US‐Gonal‐f® RFF Redi‐ject®, EU‐Gonal‐f®, and to Evaluate Safety in Healthy Adult FemaleVolunteers
Epistemonikos ID: fb02b89bdfb682ebd337f48d11d6b6e189d1e9e4
First added on: Sep 01, 2026